Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
The Minutes
Also in Government
Government
FDA Guidance Recap Podcast
by U.S. Food and Drug Administration
Today: #82 in Government, India on our combined chart.
Today: #147 in Government, Japan on our combined chart.
Chart positions today · United States
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the Philippines charts we track today.
Not on the South Africa charts we track today.
If you like FDA Guidance Recap Podcast, try…
Government Contracts Podcasts
Also in Government
Mrs. Janiskee's AP U.S. Government and Politics Podcast
Also in Government
The Good CARMA Podcast
Also in Government
Austroads: Transport Research and Trends
Also in Government
The Week in Westminster
Also in Government
Ranking history · United States
Latest daily rankings: Oct 27. New rankings will appear after the next update.
Recent history only — this show has no current ranking on the Government chart. These are recorded positions from the last 14 days, not current rankings.
Position on the Government combined chart over the last 14 days. Toggle platforms to compare their positions. Lower rank numbers are better.
View as table
| Date | Combined Rank | Apple Podcasts |
|---|---|---|
| Oct 27 | — | — |
| Oct 16 | #125 | #122 |
| Oct 14 | #168 | #168 |
Latest episodes
-
Guidance Recap Podcast | Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations
July 7, 2026 · 9 minGuidance Recap Podcast | Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations
-
Guidance Recap Podcast | Master Protocols for Drug and Biological Product Development
June 22, 2026 · 15 minGuidance Recap Podcast | Master Protocols for Drug and Biological Product Development
-
Guidance Recap Podcast | Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products
March 25, 2026 · 13 minGuidance Recap Podcast | Use of Bayesian Methodology in Clinical Trials of Drug and Biological Products
-
Guidance Recap Podcast | Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments
October 22, 2025 · 9 minGuidance Recap Podcast: Selecting, Developing or Modifying Fit-for-Purpose Clinical Outcomes Assessments
-
Guidance Recap Podcast | Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development
October 16, 2024 · 12 minGuidance Recap Podcast | Considerations for Long-Term Clinical Neurodevelopmental Safety Studies in Neonatal Product Development
Show 7 more episodesShow fewer episodes
-
Guidance Recap Podcast | Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies
September 18, 2024 · 18 minGuidance Recap Podcast | Clinical Pharmacology Considerations for Human Radiolabeled Mass Balance Studies
-
Guidance Recap Podcast | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations
July 24, 2024 · 24 minGuidance Recap Podcast | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations
-
Guidance Recap Podcast | Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics
July 15, 2024 · 15 minGuidance Recap Podcast | Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics
-
Guidance Recap Podcast | E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-approval or Post-approval Clinical Trials
April 22, 2024 · 12 minGuidance Recap Podcast | E19 A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-approval or Post-approval Clinical Trials
-
Guidance Recap Podcast | Pharmacokinetics Study Design Considerations in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing
April 16, 2024 · 12 minGuidance Recap Podcast | Pharmacokinetics Study Design Considerations in Patients with Impaired Renal Function — Study Design, Data Analysis, and Impact on Dosing
-
Guidance Recap Podcast | Clinical Pharmacology Considerations for Antibody-Drug Conjugates
March 26, 2024 · 12 minGuidance Recap Podcast | Clinical Pharmacology Considerations for Antibody-Drug Conjugates
-
Guidance Recap Podcast | Drug-Drug Interaction Assessment for Therapeutic Proteins
December 11, 2023 · 13 minGuidance Recap Podcast | Drug-Drug Interaction Assessment for Therapeutic Proteins
About the show
The Guidance Recap Podcast provides highlights for FDA guidance documents straight from the authors. Through conversations with FDA staff, this podcast is intended help communicate salient key points and background information about a subset of cross-cutting guidance documents on topics that seek to modernize and accelerate drug development.